ROCO
4729
Market cap48mUSD
Oct 08, Last price
19.45TWD
1D
-0.77%
1Q
-9.11%
Jan 2017
-18.04%
IPO
-66.04%
Name
Mildex Optical Inc
Chart & performance
P/E
119.72
P/S
1.43
EPS
0.16
Div yield, %
2.57%
Shrs. gr., 5y
11.59%
Rev. gr., 5y
3.29%
Revenues
1.07b
+8.46%
Net income
13m
-58.67%
CFO
135m
-15.29%
Dividend
Apr 18, 20250.5 TWD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Mildex Optical Inc. manufactures and trades in touch panels and other products in Taiwan. It offers large size touch screens; traditional resistive touch screens; projective capacitive touch screens; resistive multi-touch screens; and sunlight readable touch screens for use in patient check-in Kiosk, diagnostic apparatus, industrial panel PC, automation equipment, smart monitoring system, IOT applications, imaging display system, ventilator/respirator, robotic surgery arm, patient monitoring system, fighter jets command system, handheld controller, rugged laptop, military vehicle/tank, treadmill, smart monitoring system, smart electronic, and self-service Kiosk applications. The company also provides touch display module. Mildex Optical Inc. was incorporated in 2005 and is based in Kaohsiung, Taiwan.
Key people
Peirong Huang
Deputy General Manager
Shujing Hong
Corporate Governance Officer · since 2023
Weijing Weng
Head of Finance · since 2019
Director · since 2012
Chairman of the Board · since 2017
Qihui Huang
Director · since 2023
General Manager, Director · since 2020
Weizhi Liu
Director · since 2019
Independent Director
Fangde Ye
Independent Director · since 2020
Zhiming Zhang
Independent Director · since 2020
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||